Corient Capital Partners’s Cardinal Health CAH Stock Holding History

Corient Capital Partners’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$277K	Buy	5,297 +327	+7%	+$20.7K	0.02%	489
2022 Q2	$260K	Buy	4,970 +398	+9%	+$22.6K	0.02%	526
2022 Q1	$259K	Buy	+4,572	New	+$245K	0.02%	596
2021 Q3	–	Sell	-4,286	Closed	-$245K	–	704
2021 Q2	$245K	Buy	4,286 +326	+8%	+$19K	0.02%	557
2021 Q1	$240K	Buy	+3,960	New	+$219K	0.02%	511
2020 Q3	–	Sell	-5,202	Closed	-$272K	–	512
2020 Q2	$272K	Buy	5,202 +807	+18%	+$41.6K	0.03%	359
2020 Q1	$211K	Sell	4,395 -12,784	-74%	-$664K	0.03%	347
2019 Q4	$869K	Sell	17,179 -2,175	-11%	-$112K	0.11%	195
2019 Q3	$914K	Sell	19,354 -7,196	-27%	-$328K	0.13%	171
2019 Q2	$1.25M	Buy	+26,550	New	+$1.22M	0.19%	145
2019 Q1	–	Sell	-42,527	Closed	-$1.9M	–	356
2018 Q4	$1.9M	Buy	+42,527	New	+$2.22M	0.34%	84

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corient Capital Partners's CAH Position: Q3 2022 in Review

Corient Capital Partners increased its Cardinal Health (CAH) stake by 6.6% in Q3 2022, buying an estimated $20.7K and bringing the position to 5,297 shares worth $277K. The position accounts for 0.02% of the portfolio, ranked #489.

Corient Capital Partners first reported a position in CAH in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.9M in Q4 2018. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

Corient Capital Partners held 5,297 shares of Cardinal Health worth $277K as of Q3 2022.
Corient Capital Partners bought 327 Cardinal Health shares in Q3 2022, an estimated $20.7K.
Cardinal Health made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #489 holding.
Corient Capital Partners first reported a position in Cardinal Health in Q4 2018 and has held it in 11 quarters since.
Corient Capital Partners's Cardinal Health position peaked at $1.9M in Q4 2018.
849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.